2020 Nobel Prize in Physiology or Medicine

Last updated
Nobel prize medal.svg The 2020 Nobel Prize in Physiology or Medicine
Harvey J Alter 2020 (cropped).jpg Prof Michael Houghton (cropped2).jpg Charles M. Rice (cropped).jpg
Alter, Houghton and Rice "for the discovery of Hepatitis C virus."
Date5 October 2020 (2020-10-05)
Location Stockholm
CountrySweden
Presented by Nobel Assembly at Karolinska Institutet
Hosted by Thomas Perlmann
Reward(s)9 million SEK (2017) [1]
First awarded1901
2020 laureates Harvey J. Alter, Michael Houghton, and Charles M. Rice
Website 2020 Nobel Prize in Physiology or Medicine
  2019  · Nobel Prize in Physiology or Medicine ·  2021  

The 2020 Nobel Prize in Physiology or Medicine was awarded to the American virologists Harvey J. Alter (b. 1935), Michael Houghton (b. 1949) and Charles M. Rice (b. 1952) "for the discovery of Hepatitis C virus." [2] [3] [4] During the award ceremony on December 10, 2020, Prof. Gunilla Karlsson-Hedestam said:

Contents

"The discovery of the Hepatitis C virus by this year’s Laureates laid the foundation for our current understanding about how the virus survives in its niche during the long chronic phase of the infection, and how liver disease develops. And importantly, it led to the development of highly effective anti-viral medicines that now cure the infection in almost all treated persons." [5]

Laureates

Seminal experiments by HJ Alter, M Houghton and CM Rice leading to the discovery of HCV as the causative agent of non-A, non-B hepatitis. 15 Hegasy Nobel Prize 2020 HepC.jpg
Seminal experiments by HJ Alter, M Houghton and CM Rice leading to the discovery of HCV as the causative agent of non-A, non-B hepatitis.

Harvey J. Alter

Alter was born in New York City [6] in a Jewish family. [7] He attended the University of Rochester in Rochester, New York, and earned a Bachelor of Arts degree in 1956. In 1960, Alter obtained a medical degree from University of Rochester [8] [9] and began a residency at Strong Memorial. Alters's post graduate training includes a rotation as a clinical associate at the National Institutes of Health in Bethesda, Maryland, from December 1961 to June 1964; [10] [7] [11] a year of residency in medicine at University of Washington School of Medicine, Seattle, Washington, [12] from July 1964 to June 1965; and work as a hematology fellow at Georgetown University Hospital, Washington, D.C., from July 1965 to June 1966. [10] He has been senior investigator in the Department of Transfusion Medicine at the NIH from July 1969 to present; chief of infectious diseases section at the department of transfusion medicine in the Clinical Center NIH from December 1972 to present; associate director for research at the department of transfusion medicine at the Clinical Center at NIH from January 1987 to present. [10] He was the recipient of 1992 Karl Landsteiner Memorial Award, the 2002 Lasker-DeBakey Clinical Medical Research Award or his work leading to the discovery of the virus that causes hepatitis C, and 2013 Gairdner Foundation International Award. [13]

Michael Houghton

Michael James Houghton was born in 1949 in the United Kingdom. He received his Ph.D. degree in biochemistry in 1977 from King's College London. He joined the G. D. Searle & Company before moving in 1982 to Chiron Corporation in California. He relocated to the University of Alberta in 2010 and is currently a professor of virology at the University of Alberta where he is also director of the Li Ka Shing Applied Virology Institute. [14] He was a recipient of numerous prizes such as 1992 Karl Landsteiner Memorial Award (together with Harvey J. Alter), the 1994 William Beaumont Prize, and the 2002 Lasker Award. [15]

Charles M. Rice

Charles Moen Rice was born in 1952 in Sacramento, California. He received his Ph.D. degree in 1981 from the California Institute of Technology where he also trained as a postdoctoral fellow between 1981 and 1985. He established his research group at Washington University School of Medicine in 1986 and became a full professor in 1995. Since 2001, he has been professor at the Rockefeller University in New York. During 2001–2018, he was the Scientific and Executive Director at the Center for the Study of Hepatitis C at Rockefeller University where he remains active. [16] He was the recipient of the 2007 M.W. Beijerinck Virology Prize, the 2015 Robert Koch Prize, and the 2016 Lasker Award (with Michael J. Sofia and Ralf F. W. Bartenschlager). [17]

Key publications

The following publications were the fundamental researches that motivated the Nobel Assembly at Karolinska Institutet to award the 2020 Prize to Alter, Houghton and Rice: [18]

Harvey J. Alter

Michael Houghton

Charles M. Rice

Collaborative work

Related Research Articles

<span class="mw-page-title-main">Hepatitis C</span> Human viral infection

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; it is a type of viral hepatitis. During the initial infection period, people often have mild or no symptoms. Early symptoms can include fever, dark urine, abdominal pain, and yellow tinged skin. The virus persists in the liver, becoming chronic, in about 70% of those initially infected. Early on, chronic infection typically has no symptoms. Over many years however, it often leads to liver disease and occasionally cirrhosis. In some cases, those with cirrhosis will develop serious complications such as liver failure, liver cancer, or dilated blood vessels in the esophagus and stomach.

<span class="mw-page-title-main">Hepatology</span> Medical specialty

Hepatology is the branch of medicine that incorporates the study of liver, gallbladder, biliary tree, and pancreas as well as management of their disorders. Although traditionally considered a sub-specialty of gastroenterology, rapid expansion has led in some countries to doctors specializing solely on this area, who are called hepatologists.

<span class="mw-page-title-main">Baruch Samuel Blumberg</span> American doctor (1925–2011)

Baruch Samuel Blumberg, known as Barry Blumberg, was an American physician, geneticist, and co-recipient of the 1976 Nobel Prize in Physiology or Medicine, for his work on the hepatitis B virus while an investigator at the NIH and at the Fox Chase Cancer Center. He was president of the American Philosophical Society from 2005 until his death.

<span class="mw-page-title-main">Rockefeller University</span> Biomedical research university in New York City, US

The Rockefeller University is a private biomedical research and graduate-only university in New York City, New York. It focuses primarily on the biological and medical sciences and provides doctoral and postdoctoral education. It is classified as a as a "Special Focus - Research Institution." Rockefeller is the oldest biomedical research institute in the United States.

<span class="mw-page-title-main">Harold E. Varmus</span> American scientist (born 1939)

Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.

<span class="mw-page-title-main">Hepatitis C virus</span> Species of virus

The hepatitis C virus (HCV) is a small, enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer and lymphomas in humans.

<span class="mw-page-title-main">Joseph L. Goldstein</span> American biochemist

Joseph Leonard Goldstein ForMemRS is an American biochemist. He received the Nobel Prize in Physiology or Medicine in 1985, along with fellow University of Texas Southwestern researcher, Michael Brown, for their studies regarding cholesterol. They discovered that human cells have low-density lipoprotein (LDL) receptors that remove cholesterol from the blood and that when LDL receptors are not present in sufficient numbers, individuals develop hypercholesterolemia and become at risk for cholesterol related diseases, notably coronary heart disease. Their studies led to the development of statin drugs.

<span class="mw-page-title-main">Harvey J. Alter</span> American medical researcher

Harvey James Alter is an American medical researcher, virologist, physician and Nobel Prize laureate, who is best known for his work that led to the discovery of the hepatitis C virus. Alter is the former chief of the infectious disease section and the associate director for research of the Department of Transfusion Medicine at the Warren Grant Magnuson Clinical Center in the National Institutes of Health (NIH) in Bethesda, Maryland. In the mid-1970s, Alter and his research team demonstrated that most post-transfusion hepatitis cases were not due to hepatitis A or hepatitis B viruses. Working independently, Alter and Edward Tabor, a scientist at the U.S. Food and Drug Administration, proved through transmission studies in chimpanzees that a new form of hepatitis, initially called "non-A, non-B hepatitis" caused the infections, and that the causative agent was probably a virus. This work eventually led to the discovery of the hepatitis C virus in 1988, for which he shared the Nobel Prize in Physiology or Medicine in 2020 along with Michael Houghton and Charles M. Rice.

<span class="mw-page-title-main">Francis Peyton Rous</span> American scientist (1879–1970)

Francis Peyton Rous was an American pathologist at the Rockefeller University known for his works in oncoviruses, blood transfusion and physiology of digestion. A medical graduate from the Johns Hopkins University, he was discouraged to become a practicing physician due to severe tuberculosis. After three years of working as an instructor of pathology at the University of Michigan, he became dedicated researcher at the Rockefeller Institute for Medical Research for the rest of his career.

<span class="mw-page-title-main">Karl Landsteiner</span> Austrian immunologist (1868–1943)

Karl Landsteiner was an Austrian American biologist, physician, and immunologist. He emigrated with his family to New York in 1923 at the age of fifty five for professional opportunities, working for the Rockefeller Institute.

<span class="mw-page-title-main">Michael Houghton</span> British virologist (born 1949)

Sir Michael Houghton is a British scientist and Nobel Prize laureate. Along with Qui-Lim Choo, George Kuo and Daniel W. Bradley, he co-discovered Hepatitis C in 1989. He also co-discovered the Hepatitis D genome in 1986. The discovery of the Hepatitis C virus (HCV) led to the rapid development of diagnostic reagents to detect HCV in blood supplies, which has reduced the risk of acquiring HCV through blood transfusion from one in three to about one in two million. It is estimated that antibody testing has prevented at least 40,000 new infections per year in the US alone and many more worldwide.

Qui-Lim Choo is a Singapore-born scientist, who along with Michael Houghton, George Kuo and Daniel W. Bradley, co-discovered and cloned Hepatitis C in 1989. He also co-discovered the Hepatitis D genome in 1986. The discovery of Hepatitis C led to the rapid development of diagnostic reagents to detect Hepatitis C virus in blood supplies which has reduced the risk of acquiring hepatitis C through blood transfusion from one in three to about one in two million. It is estimated that antibody testing has prevented at least 40,000 new infections per year in the US alone and many more worldwide.

Alton Ivan Sutnick is an American medical researcher, educator and administrator. He is the author of over 200 scholarly publications.

Stephen Mark Feinstone is a virologist who, together with Albert Kapikian and Robert Purcell, co-identified the Hepatitis A virus (HAV) in 1973.

<span class="mw-page-title-main">Robert Purcell (virologist)</span>

Robert Harry Purcell is an American virologist and former co-chief of the Laboratory of Infectious Diseases at the U.S. National Institute of Allergy and Infectious Disease. He is known for his work on hepatitis viruses, and was involved in identifying hepatitis A virus, hepatitis D virus, and hepatitis E virus, developing an animal model for hepatitis B, and developing the hepatitis A vaccine.

<span class="mw-page-title-main">Charles M. Rice</span> American virologist

Charles Moen Rice is an American virologist and Nobel Prize laureate whose main area of research is the hepatitis C virus. He is a professor of virology at the Rockefeller University in New York City and an adjunct professor at Cornell University and Washington University School of Medicine. At the time of the award he was a faculty at Rockefeller.

<span class="mw-page-title-main">Gregg L. Semenza</span> American physician

Gregg Leonard Semenza is a pediatrician and Professor of Genetic Medicine at the Johns Hopkins School of Medicine. He serves as the director of the vascular program at the Institute for Cell Engineering. He is a 2016 recipient of the Albert Lasker Award for Basic Medical Research. He is known for his discovery of HIF-1, which allows cancer cells to adapt to oxygen-poor environments. He shared the 2019 Nobel Prize in Physiology or Medicine for "discoveries of how cells sense and adapt to oxygen availability" with William Kaelin Jr. and Peter J. Ratcliffe. Semenza has had ten research papers retracted due to falsified data.

<span class="mw-page-title-main">William Kaelin Jr.</span> American Nobel Laureate, Professor of Medicine at Harvard University

William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.

Michael J. Sofia is a chemist whose main research focus is hepatitis C virus and hepatitis B virus drug discovery. He was a co-recipient of the Lasker-DeBakey Clinical Medical Research Award for his work on hepatitis C in 2016 and of the Gertrude B. Elion Memorial Award from the International Society for Antiviral Research in 2017.

<span class="mw-page-title-main">Drew Weissman</span> American physician and immunologist (born 1959)

Drew Weissman is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).

References

  1. "Nobel Prize amount is raised by SEK 1 million". Nobelprize.org. Archived from the original on 1 February 2018. Retrieved 5 October 2020.
  2. The Nobel Prize in Physiology or Medicine 2020 nobelprize.org
  3. Katherine J. Wu and Daniel Victor (5 October 2020). "Nobel Prize in Medicine Awarded to Scientists Who Discovered Hepatitis C Virus". The New York Times. Retrieved 20 August 2022.
  4. Rob Stein (5 October 2020). "3 Scientists Win Nobel Prize For Hepatitis C Virus Discovery". National Public Radio . Retrieved 20 August 2022.
  5. Award ceremony speech - 2020 Nobel Prize in Physiology or Medicine nobelprize.org
  6. Henrichsen, Colleen (September 21, 2000). "NIH Clinical Center scientist a Lasker Award recipient". Press release. NIH. Retrieved October 20, 2009.
  7. 1 2 Alter, Harvey J. (2014). "The road not taken or how I learned to love the liver: A personal perspective on hepatitis history". Hepatology. 59 (1): 4–12. doi: 10.1002/hep.26787 . ISSN   1527-3350. PMID   24123147. S2CID   30040670.
  8. "Rochester graduate awarded 2020 Nobel Prize for 'landmark achievement' against hepatitis". NewsCenter. October 5, 2020. Retrieved October 5, 2020.
  9. Freile, Victoria E. (October 6, 2020). "UR graduate Harvey Alter awarded Nobel Prize in fight against Hepatitis". Democrat and Chronicle. Retrieved October 6, 2020.
  10. 1 2 3 "Harvey J. Alter Curriculum Vitae". Archived from the original on September 4, 2005. Retrieved April 21, 2006.
  11. National Institutes of Health (U.S.). Clinical Center (1958). Report of program activities : National Institutes of Health. Clinical Center. NIH Library. Bethesda, Md. : The Center.
  12. Alter, Harvey J.; Klein, Harvey G. (October 1, 2008). "The hazards of blood transfusion in historical perspective". Blood. 112 (7): 2617–2626. doi:10.1182/blood-2008-07-077370. ISSN   0006-4971. PMC   2962447 . PMID   18809775.
  13. Harvey J. Alter nobelprize.org
  14. Michael Houghton – Facts nobelprize.org
  15. Michael Houghton britannica.com
  16. Charles M. Rice – Facts nobelprize.org
  17. Charles M. Rice britannica.com
  18. Press release: The Nobel Prize in Physiology or Medicine 2020 nobelprize.org